This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease.
Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.
Auflage
Sprache
Verlagsort
Zielgruppe
Illustrationen
7
24 farbige Abbildungen, 7 s/w Abbildungen
VIII, 324 p. 31 illus., 24 illus. in color.
Maße
Höhe: 241 mm
Breite: 160 mm
Dicke: 23 mm
Gewicht
ISBN-13
978-981-16-4520-4 (9789811645204)
DOI
10.1007/978-981-16-4521-1
Schweitzer Klassifikation
Seigo Nakamura
Department of Breast Surgical Oncology
Showa University, School of Medicine
Tokyo, Japan
Daisuke Aoki
Department of Obstetrics and Gynecology,
Keio University School of Medicine,
Tokyo, Japan
Yoshio Miki
Department of Molecular Genetics, Medical Research Institute,
Tokyo Medical and Dental University,
Tokyo, Japan